Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2013 (2013), Article ID 121956, 11 pages
http://dx.doi.org/10.1155/2013/121956
Research Article

Role of Peroxisome Proliferator-Activated Receptor and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells

1Department of Veterinary and Biomedical Sciences and Center for Molecular Toxicology and Carcinogenesis, Penn State University, 325 Life Sciences Building, University Park, PA 16802, USA
2Department of Pharmacology, Penn State University, Hershey, PA 17033, USA
3Penn State Cancer Institute, Hershey, PA 17033, USA
4Indigo Biosciences Inc., State College, PA 16801, USA

Received 9 January 2013; Revised 18 March 2013; Accepted 7 April 2013

Academic Editor: Annamaria Cimini

Copyright © 2013 Jeffrey D. Coleman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Maitra and R. H. Hruban, “Pancreatic cancer,” Annual Review of Pathology: Mechanisms of Disease, vol. 3, pp. 157–188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. B. Lowenfels and P. Maisonneuve, “Epidemiology and risk factors for pancreatic cancer,” Best Practice and Research: Clinical Gastroenterology, vol. 20, no. 2, pp. 197–209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. S. Michaud, S. Liu, E. Giovannucci, W. C. Willett, G. A. Colditz, and C. S. Fuchs, “Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study,” Journal of the National Cancer Institute, vol. 94, no. 17, pp. 1293–1300, 2002. View at Google Scholar · View at Scopus
  4. D. S. Michaud, A. Vrieling, L. Jiao et al., “Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan),” Cancer Causes and Control, vol. 21, no. 8, pp. 1213–1225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Everhart and D. Wright, “Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis,” Journal of the American Medical Association, vol. 273, no. 20, pp. 1605–1609, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Raimondi, P. Maisonneuve, and A. B. Lowenfels, “Epidemiology of pancreatic cancer: an overview,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 12, pp. 699–708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. E. Adrian, “Inhibition of pancreatic cancer cell growth,” Cellular and Molecular Life Sciences, vol. 64, no. 19-20, pp. 2512–2521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Goldstein, S. Carroll, M. Apte, and G. Keogh, “Modern management of pancreatic carcinoma,” Internal Medicine Journal, vol. 34, no. 8, pp. 475–481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Chawta, J. J. Repa, R. M. Evans, and D. J. Mangelsdorf, “Nuclear receptors and lipid physiology: opening the x-files,” Science, vol. 294, no. 5548, pp. 1866–1870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Lemberger, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology,” Annual Review of Cell and Developmental Biology, vol. 12, pp. 335–363, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Fredenrich and P. A. Grimaldi, “PPAR delta: an uncompletely known nuclear receptor,” Diabetes and Metabolism, vol. 31, no. 1, pp. 23–27, 2005. View at Google Scholar · View at Scopus
  12. A. Cimini and M. P. Cerù, “Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation,” Stem Cell Reviews, vol. 4, no. 4, pp. 293–303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Michalik, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptors β/δ: emerging roles for a previously neglected third family member,” Current Opinion in Lipidology, vol. 14, no. 2, pp. 129–135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Bishop-Bailey and J. Bystrom, “Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation,” Pharmacology and Therapeutics, vol. 124, no. 2, pp. 141–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. H. Lee, A. Chawla, N. Urbiztondo, D. Liao, W. A. Boisvert, and R. M. Evans, “Transcriptional repression of atherogenic inflammation: modulation by PPARδ,” Science, vol. 302, no. 5644, pp. 453–457, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Kharroubi, C. H. Lee, P. Hekerman et al., “BCL-6: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells,” Diabetologia, vol. 49, no. 10, pp. 2350–2358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Higashiyama, A. N. Billin, Y. Okamoto, M. Kinoshita, and S. Asano, “Expression profiling of Peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray,” Histochemistry and Cell Biology, vol. 127, no. 5, pp. 485–494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Pandol, M. Edderkaoui, I. Gukovsky, A. Lugea, and A. Gukovskaya, “Desmoplasia of pancreatic ductal adenocarcinoma,” Clinical Gastroenterology and Hepatology, vol. 7, no. 11, pp. S44–S47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Halbersztadt, A. Haloń, J. Pajak, J. Robaczyński, J. Rabczynski, and M. St Gabryś, “The role of matrix metalloproteinases in tumor invasion and metastasis,” Ginekologia Polska, vol. 77, no. 1, pp. 63–71, 2006. View at Google Scholar · View at Scopus
  20. E. I. Deryugina and J. P. Quigley, “Matrix metalloproteinases and tumor metastasis,” Cancer and Metastasis Reviews, vol. 25, no. 1, pp. 9–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Bloomston, E. E. Zervos, and A. S. Rosemurgy, “Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials,” Annals of Surgical Oncology, vol. 9, no. 7, pp. 668–674, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. W. Roomi, J. C. Monterrey, T. Kalinovsky, M. Rath, and A. Niedzwiecki, “Patterns of MMP-2 and MMP-9 expression in human cancer cell lines,” Oncology Reports, vol. 21, no. 5, pp. 1323–1333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. Kim, M. Y. Kim, J. S. Hwang et al., “PPARδ inhibits IL-1β-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra,” Cellular and Molecular Life Sciences, vol. 67, no. 12, pp. 2119–2130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Nakajima, A. Tomimoto, K. Fujita et al., “Inhibition of peroxisome proliferator-activated receptor γ activity suppresses pancreatic cancer cell motility,” Cancer Science, vol. 99, no. 10, pp. 1892–1900, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Farrow and B. M. Evers, “Activation of PPARγ increases PTEN expression in pancreatic cancer cells,” Biochemical and Biophysical Research Communications, vol. 301, no. 1, pp. 50–53, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Hashimoto, B. J. Farrow, and B. M. Evers, “Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2,” Pancreas, vol. 28, no. 2, pp. 153–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. T. C. He, T. A. Chan, B. Vogelstein, and K. W. Kinzler, “PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs,” Cell, vol. 99, no. 3, pp. 335–345, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. B. H. Park, B. Vogelstein, and K. W. Kinzler, “Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2598–2603, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Bastie, “PPARδ and PPARγ: roles in fatty acids signalling, implication in tumorigenesis,” Bulletin du Cancer, vol. 89, no. 1, pp. 23–28, 2002. View at Google Scholar · View at Scopus
  30. B. Glinghammar, J. Skogsberg, A. Hamsten, and E. Ehrenborg, “PPARδ activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells,” Biochemical and Biophysical Research Communications, vol. 308, no. 2, pp. 361–368, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Romanowska, N. Al Yacoub, H. Seidel et al., “PPARδ enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor,” Journal of Investigative Dermatology, vol. 128, no. 1, pp. 110–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. A. D. Burdick, M. T. Bility, E. E. Girroir et al., “Ligand activation of peroxisome proliferator-activated receptor-β/δ(PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes,” Cellular Signalling, vol. 19, no. 6, pp. 1163–1171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. H. E. Hollingshead, R. L. Killins, M. G. Borland et al., “Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell lines,” Carcinogenesis, vol. 28, no. 12, pp. 2641–2649, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Kilian, J. I. Gregor, I. Heukamp et al., “Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 75, no. 6, pp. 429–434, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Tian, Y. Z. Cui, G. H. Song et al., “Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients,” BMC Cancer, vol. 8, article 241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Fan, Y. Wang, Z. Tang et al., “Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 315–321, 2008. View at Google Scholar
  37. R. L. Stephen, M. C. U. Gustafsson, M. Jarvis et al., “Activation of peroxisome proliferator-activated receptor δ stimulates the proliferation of human breast and prostate cancer cell lines,” Cancer Research, vol. 64, no. 9, pp. 3162–3170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Kawa, T. Nikaido, H. Unno, N. Usuda, K. Nakayama, and K. Kiyosawa, “Growth inhibition and differentiation of pancreatic cancer cell lines by PPARγ ligand troglitazone,” Pancreas, vol. 24, no. 1, pp. 1–7, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Eibl, “The role of PPAR-γ and its interaction with COX-2 in pancreatic cancer,” PPAR Research, vol. 2008, Article ID 326915, 6 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. G. G. Mackenzie, S. Rasheed, W. Wertheim, and B. Rigas, “NO-donating NSAIDs, PPARδ, and cancer: does PPARδ contribute to colon carcinogenesis?” PPAR Research, vol. 2008, Article ID 919572, 11 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. H. E. Marin, M. A. Peraza, A. N. Billin et al., “Ligand activation of peroxisome proliferator-activated receptor β inhibits colon carcinogenesis,” Cancer Research, vol. 66, no. 8, pp. 4394–4401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. D. J. Kim, M. T. Bility, A. N. Billin, T. M. Willson, F. J. Gonzalez, and J. M. Peters, “PPARβ/δ selectively induces differentiation and inhibits cell proliferation,” Cell Death and Differentiation, vol. 13, no. 1, pp. 53–60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. D. J. Kim, K. Sandeep Prabhu, F. J. Gonzalez, and J. M. Peters, “Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ),” Carcinogenesis, vol. 27, no. 5, pp. 1105–1112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Yang, E. D. Staren, J. M. Howard, T. Iwamura, J. E. Bartsch, and H. E. Appert, “Invasiveness and MMP expression pancreatic carcinoma,” Journal of Surgical Research, vol. 98, no. 1, pp. 33–39, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Maatta, Y. Soini, A. Liakka, and H. Autio-Harmainen, “Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis,” Clinical Cancer Research, vol. 6, no. 7, pp. 2726–2734, 2000. View at Google Scholar · View at Scopus
  46. J. D. Evans, P. Ghaneh, A. Kawesha, and J. P. Neoptolemos, “Role of matrix metalloproteinases and their inhibitors in pancreatic cancer,” Digestion, vol. 58, no. 6, pp. 520–528, 1997. View at Google Scholar · View at Scopus
  47. C. S. Lee, J. Montebello, T. Georgiou, and J. Rode, “Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis,” International Journal of Experimental Pathology, vol. 75, no. 2, pp. 79–83, 1994. View at Google Scholar · View at Scopus
  48. R. M. Senior, G. L. Griffin, C. J. Fliszar, S. D. Shapiro, G. I. Goldberg, and H. G. Welgus, “Human 92- and 72-kilodalton type IV collagenases are elastases,” Journal of Biological Chemistry, vol. 266, no. 12, pp. 7870–7875, 1991. View at Google Scholar · View at Scopus
  49. K. Guo, Q. Ma, L. Wang et al., “Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol,” Oncology Reports, vol. 22, no. 4, pp. 825–830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. O. Takayama, H. Yamamoto, B. Damdinsuren et al., “Expression of PPARδ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology,” British Journal of Cancer, vol. 95, no. 7, pp. 889–895, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. N. S. Tan, L. Michalik, N. Di-Poï et al., “Essential role of Smad3 in the inhibition of inflammation-induced PPARβ/δ expression,” The EMBO Journal, vol. 23, no. 21, pp. 4211–4221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. D. A. Glauser and W. Schlegel, “The FoxO/Bcl-6/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic β-cells,” Journal of Receptors and Signal Transduction, vol. 29, no. 6, pp. 293–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. L. M. Toney, G. Cattoretti, J. A. Graf et al., “BCL-6 regulates chemokine gene transcription in macrophages,” Nature Immunology, vol. 1, no. 3, pp. 214–220, 2000. View at Google Scholar · View at Scopus
  54. I. Wlodarska, P. Nooyen, B. Maes et al., “Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma,” Blood, vol. 101, no. 2, pp. 706–710, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. M. G. Tibiletti, V. Martin, B. Bernasconi et al., “BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome,” Human Pathology, vol. 40, no. 5, pp. 645–652, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Tzankov, A. Schneider, S. Hoeller, and S. Dirnhofer, “Prognostic importance of BCL6 rearrangements in diffuse large B-cell lymphoma with respect to Bcl6 protein levels and primary lymphoma site,” Human Pathology, vol. 40, no. 7, pp. 1055–1056, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Shvarts, T. R. Brummelkamp, F. Scheeren et al., “A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling,” Genes and Development, vol. 16, no. 6, pp. 681–686, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Holzmann, H. Kohlhammer, C. Schwaenen et al., “Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes,” Cancer Research, vol. 64, no. 13, pp. 4428–4433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Perez-Rosado, M. J. Artiga, P. Vargiu, A. Sanchez-Aguilera, A. Alvarez-Barrientos, and M. A. Piris, “BCL6 represses NFκB activity in diffuse large B-cell lymphomas,” Journal of Pathology, vol. 214, no. 4, pp. 498–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Takada, K. Hirata, T. Ajiki, Y. Suzuki, and Y. Kuroda, “Expression of Receptor for Advanced Glycation End products (RAGE) and MMP-9 in human pancreatic cancer cells,” Hepato-Gastroenterology, vol. 51, no. 58, pp. 928–930, 2004. View at Google Scholar · View at Scopus
  61. A. A. Tempia-Caliera, L. Z. Horvath, A. Zimmermann et al., “Adhesion molecules in human pancreatic cancer,” Journal of Surgical Oncology, vol. 79, no. 2, pp. 93–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Friess, P. Berberat, M. Schilling, J. Kunz, M. Korc, and M. W. Büchler, “Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors,” Journal of Molecular Medicine, vol. 74, no. 1, pp. 35–42, 1996. View at Google Scholar · View at Scopus
  63. C. Y. Wu, H. L. Hsieh, C. C. Sun, and C. M. Yang, “IL-1β induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-Jun cascade in rat brain astrocytes,” GLIA, vol. 57, no. 16, pp. 1775–1789, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. G. M. Gordon, D. R. Ledee, W. J. Feuer, and M. E. Fini, “Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cellsy,” Journal of Cellular Physiology, vol. 221, no. 2, pp. 402–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Li, F. Q. Xing, and S. L. Chen, “Role of interleukin-1beta in regulating human cultured endometrial cell MMP-9 and TIMP-3 expressions in the mid-secretory phase,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 26, no. 8, pp. 1143–1145, 2006. View at Google Scholar · View at Scopus
  66. E. Greco, D. Basso, P. Fogar et al., “Pancreatic cancer cells invasiveness is mainly affected by interleukin-1β not by transforming growth factor-β1,” International Journal of Biological Markers, vol. 20, no. 4, pp. 235–241, 2005. View at Google Scholar · View at Scopus
  67. H. Takaya, A. Andoh, M. Shimada, K. Hata, Y. Fujiyama, and T. Bamba, “The expression of chemokine genes correlates with nuclear factor-κB activation in human pancreatic cancer cell lines,” Pancreas, vol. 21, no. 1, pp. 32–40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. G. Solinas, F. Marchesi, C. Garlanda, A. Mantovani, and P. Allavena, “Inflammation-mediated promotion of invasion and metastasis,” Cancer and Metastasis Reviews, vol. 29, no. 2, pp. 243–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. G. G. Vaday, H. Schor, M. A. Rahat, N. Lahat, and O. Lider, “Transforming growth factor-β suppresses tumor necrosis factor α-induced matrix metalloproteinase-9 expression in monocytes,” Journal of Leukocyte Biology, vol. 69, no. 4, pp. 613–621, 2001. View at Google Scholar · View at Scopus
  70. H. J. Kim, S. A. Ham, S. U. Kim et al., “Transforming growth factor-β1 is a molecular target for the peroxisome proliferator-activated receptor δ,” Circulation Research, vol. 102, no. 2, pp. 193–200, 2008. View at Publisher · View at Google Scholar · View at Scopus